Assessment in vitro of immunity against Toxoplasma gondii by unknown
ASSESSMENT IN VITRO OF IMMUNITY AGAINST
TOXOPLASMA GONDII
BY THOMAS C . JONES, LUCILLE LEN, AND JAMES G . HIRSCH
(From the Cornell University Medical College and The Rockefeller University, New York 10021)
Acquired immunity to intracellular microbes is known to be in many instances
primarily dependent on cellular agencies (1), involving cooperation between
lymphocytes and macrophages (2) . Lymphocytes respond to previously ex-
perienced antigens, and somehow induce macrophages to be more effective in
dealing with intracellular organisms . The macrophage response to these lympho-
cytes or lymphocyte products appears to be nonspecific in terms of the increased
immunity expressed (3) . Studies on the mechanisms involved in this cellular
immunity have proceeded along several lines, including identification of the
involved lymphocyte population as T cells (4), partial characterization of the
products of stimulated lymphocytes (5), and definition of some parameters of
macrophage morphology and physiology that correlate with enhanced effective-
ness against microbes (6) .
Use of in vitro techniques offers the opportunity to more precisely define the
specific determinants and variables in this complex cellular response . It has,
however, not always been easy to demonstrate the enhanced antimicrobial
activity of activated macrophages in vitro . Success has been reported in models
employing mycobacteria (7) and listeria (8), but technical problems may
contribute to difficulties in interpreting results obtained with this type of in vitro
system .
We report here our studies in vitro on immunity to the coccidian protozoan
Toxoplasma gondii . Use of toxoplasmas circumvents some of the technical
problems referred to above . Toxoplasmas cannot multiply extracellularly, and
studies on their intracellular fate thus are not complicated by continued uptake
of parasites growing in the medium, or by the need for antibiotics to control
extracellular growth . Toxoplasmas are sufficiently large organisms to exhibit well
developed morphologic features visible by phase-contrast microscopy, allowing
by direct observation accurate assessment of the fate of the organisms, and
measurement of their intracellular generation time . We have used the mouse as
an appropriate host to evaluate acquired cellular immunity to toxoplasmosis for
a number of reasons, but one clear advantage is the availability of a resident
* This research was supported by National Science Foundation grant GB 36437 and U . S . Public
Health Service grants AI 12146, AI 70754, and AI 01831 .
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man .
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peritoneal cell population which can be collected without resorting to irritative
techniques for producing an exudate . Furthermore, chronic toxoplasma infec-
tion, and cellular immunity to this parasite, can be reproducibly induced in mice
by subcutaneous injection of toxoplasma cysts .
Materials and Methods
Animals and Cells . 25-50 g CFW male mice were used for all experiments . A colony of
toxoplasma-infected mice was maintained by injecting the mice with brain tissue containing
toxoplasma cysts from mice previously infected with the PeC strain . The brain was mildly emulsified
usingtwo or three strokes with the pestle of a tissue homogenizer, and thehomogenate was diluted in
minimum essential medium (MEM) to a concentration of 10 cysts (1,000-10,000 organisms)/ml . 0.2
ml was injected into the left thigh . Peritoneal cells were studied from these animals at various times
after infection. Cells were collected from untreated control animals and the immunized animals by
lavage of the unstimulated peritoneal cavity with heparinized phosphate-buffered saline . Cells were
suspended in MEM and 20% heat-inactivated fetal calf serum (HIFCS)' and allowed to adhere to
glass cover slips in Falcon dishes (Falcon Plastics, Div. of BioQuest. Oxnard, CaliL) for 1 h as previ-
ously described (9) . Nonadherent cells were separated in those experiments where this was desired by
washingtwice with MEMand collecting the cell-rich wash .
Organisms . The RH strain of T . gondii was maintained by passage every 3 or 4 days in the
peritoneal cavity of mice (9) . At the time of harvesting, peritoneal exudate collected on the 3rd day of
intraperitoneal infection was diluted in 2-3 ml ofMEM, and centrifuged at 30 g for5min to remove
leukocytes and clumps of material . The toxoplasmas were then pelleted from the supernate by
centrifuging at 340g for 10 min . The pellet was resuspended inMEM and20% HIFCSand thevolume
adjusted to yielda toxoplasma concentration of 1 x 10°/ml (95% viable by trypan blue exclusion test) .
This toxoplasma suspension was used to overlay cells in culture during in vitro challenge
experiments .
The Pe strain of T. gondii was obtained from Dr . Anne Kimball, Cornell University Medical
College, New York . The strain had been isolated from the myocardium of an adult human being. It
was selected because it displayed low virulence for mice . Two substrains of this organism were
derived . One was rendered more virulent for mice (PeV) by rapid intraperitoneal passage in mice
every 5-7 days for 2 mo . 10 5 toxoplasmas of this PeV strain killed normal mice in 10-14 days . This
substrain (PeV) was used as the challenge to document immunity against toxoplasma in mice . The
second substrain (PeC, relatively attenuated in virulence for mice) was maintained as a chronic
infection in mice by passage of toxoplasma brain cysts every 2-3 mo, and was used to produce the
toxoplasma-infected and immune mouse colony described above .
Preparation ofAntigens .
￿
Toxoplasma antigen was prepared by collectingRH strain ofT. gondii 4
days after intraperitoneal infection of mice . The peritoneal exudate was diluted in approximately
equal volumes ofMEM, centrifuged at 30 g for 5min, the supernate centrifuged at 340g for 10 min,
and the toxoplasma pellet resuspended in saline to a concentration of about 10 8/ml . This was
frozen-thawed six times (acetone-dry ice to 37°C water bath), then centrifuged at 1,300g for 20 min .
The supernate was then centrifuged at 10,000 g for 1 h . The amount of protein in the final supernate
was determined by the Lowry method using a lysozyme standard . The total protein content was
correlated with the quantity oftoxoplasma complement (C)-fixing antigen . For all experiments 201+g
of toxoplasma antigen/ml of final medium was added to each dish, a quantity adequate for full
C-fixing activity in the presence of toxoplasma-positive antisera .
Antisera .
￿
Mouse, rabbit, and human sera were tested for the presence of antibodies against
toxoplasmas using the Sabin-Feldman (S-F) dye test modified for microdilution techniques as
routinelyperformed in these laboratories (10) . Sera were heat inactivated andadded to culture dishes
in a concentration of greater than 200 (S-F) antibody U/ml of final medium . Antitoxoplasma
antibody was used to treat toxoplasmas or macrophages before combining them in culture, or after
macrophage infection, dependingon the experimental design .
In Vitro Culture Techniques .
￿
Macrophages : Adherent peritoneal cells (primarily macrophages)
were separated from nonadherent cells by washing cover slips 1 h after plating the peritoneal cells . In468
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experiments in which as pure a macrophage population as possible was desired the cover slips were
washed eight times . Usually, four washes were employed to remove nonadherent cells . Adherent
peritoneal exudate cells (approximately 5 x 10°/cover slip) were overlayedwith freshMEM and 20%
HIFCS for 24 h before infection with toxoplasmas to allow for adequate spreading . Longer culture
periods were occasionally used as indicated in the Results section .
Lymphocytes .
￿
Peritoneal nonadherent cells were either cultured with the adherent population, or
removed and used to overlay different adherent populations, or removed and maintained separated
from macrophages depending on the experiment . Antigen (20 kg toxoplasma protein/ml) was added
to some ofthese cells .The cell cultures were then incubated for 24 h . This time wasfound optimal for
induction of inhibition of toxoplasma multiplication in immune macrophages . In other experiments
the media from toxoplasma antigen-lymphocyte interaction were collected and used for study of
influence on growth of toxoplasmas in macrophage cultures .
Spleen lymphocytes were collected by teasing the spleen gently with forceps in Hanks' balanced
salt solution . This mixture was decanted into a 15 ml Falcon plastic tube and the clumps were
allowed to settle . The spleen cells in suspension were transferred to another tube and centrifuged at
150 g for 5 min . The pellet was resuspended in 0.83% NH,CI to lyse red blood cells . Lymphoid cells
were centrifuged again and resuspended in MEM . These cells were found to be 85-95% viable by
trypan blue exclusion. Spleen cells used for immune supernatant preparations were suspended to a
concentration of 5 x 10° cells/1.5 ml final medium/dish . Nonadherent spleen cells were also used to
document lymphocyte transformation to toxoplasma antigen according to published procedures (11),
except that 1 x 10° cells were used per well instead of 2 x 10°.
Infection of Cultured Cells .
￿
After cultivation in vitro for 24 h the macrophage or macrophage-
lymphocyte mixtures were washed four times with MEM. 1 ml of the toxoplasma-rich suspension (1
x 10° toxoplasmas/ml/dish) in MEM-20% HIFCS was then added to the macrophages for 30 min .
The fluid was then removed, the cover slips were washed twice, and fresh MEM-20% HIFCS was
added . The dishes were incubated at 37°C in 5% C0,/air . Several types of observations were made on
toxoplasma-infected cells as previously described (9). Some macrophage monolayers were fixed 3 h
after infection to determine the presence of living and degenerating parasites . In other experiments
the infection was allowed to proceed for up to 30 h . At various times cover slips were removed, fixed in
2.5% glutaraldehyde in sodium cacodylate buffer, pH 7.4, and examined under phase-contrast
microscopy . These infected cells were monitored for morphology of toxoplasmas and macrophages .
Numerous experiments documented thatT. gondii began to divide synchronously within cytoplasmic
vacuoles after a resting period of 6-8 h. Thereafter the number of toxoplasmas per vacuole doubled
every 5 h . When more than 16 toxoplasmas were present in a macrophage, the cell tended to round
and detach from the cover slip, or to rupture . The generation time was calculated from the plot on
semilogarithmic graphs of toxoplasmas per vacuole vs . time .
Microscopy . Phase-contrast microscopy was done on glutaraldehyde-fixed specimens using a
Zeiss microscope (Carl Zeiss, Inc., NewYork) with a63 x planapophase oil immersion objective or a
100x phase oil immersion objective . Specimens for electron microscopy were fixed as described
previously (9) . Thin sections were stained with lead and uranyl solutions and examined with a
Siemens Eimiskop I (Siemens Corp ., Medical Industrial Div., Iselin, N. J.) at 80 kV using a 50 Wg
objective aperture .
Results
Alterations in Mice Infected with Toxoplasmas Attenuated in Virulence . After
infection with cysts of the PeC strain a number of changes occurred in the mice .
Between 8 days and 20 days after infection the average spleen weight of im-
munized mice rapidly increased from 200 to 650 mg . The large spleens persisted
for a variable period, but in general by 90 days they had returned to normal .
During the period of splenic hyperplasia there occurred in the spleen a marked
increase in the number of glass adherent cells, which had the characteristics of
normal mouse spleen macrophages (12) . Toxoplasmas were not identified in
histologic sections of spleen stained by Giemsa or hematoxylinandeosin.THOMAS C. JONES, LUCILLE LEN, AND JAMES G . HIRSCH
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Toxoplasma antibody appeared in the mouse plasma by 26 days after
infection, reached peak titers by 32 days, and remained elevated throughout the
life of the animal . Toxoplasma cysts in the brains of the infected mice could first
be detected by light microscopy 23 days after infection, and remained present
throughout the life of the animal .
These infected mice were tested for immunity by challenge withan intraperito-
neal inoculation of 105 organisms of the mouse virulent, PeV strain of T. gondii at
5 days, 11 days, 44 days, and 320 days after infection . This dose and route of
PeV T . gondii consistently killed all normal mice, whereas some of the infected
mice survived when challenged 11 days after infection-immunity, and all sur-
vived at later challenge times . These chronically infected mice therefore demon-
strated striking immunity, and were used as "immunized" animals in the experi-
ments describedbelow .
Effects of Antibodies to Toxoplasma on Survival and Growth of these
Organisms In Vitro . One of the changes in the immunized mice correlated in
general with their immunity to challenge with virulent toxoplasmas was the
appearance of serum antibody detectable by the S-F dye test . Although previous
work had indicated the predominant role of cellular changes, rather than
antibody, in acquired immunity to this organism (13), it was nevertheless of
interest to examine the effects of antibody on toxoplasmas and on their
interactions with various cells . As previously demonstrated inmany laboratories,
fresh antiserum against toxoplasmas exerted a lethal action, whereas heat-inac-
tivated antisera did not cause morphologic changes in the parasite . Toxoplasmas
readily gain entry by the phagocytic route into macrophages or fibroblasts in the
absence of antibody (9) . Toxoplasmas exposed to heat-inactivated antitoxo-
plasma antibody, human or mouse, lost their ability to enter fibroblasts or HeLa
cells, but were rapidly ingested by macrophages . The fate of these antibody-
treated toxoplasmas in macrophages was however altered markedly . In the
absence of antibody exposure, approximately half the toxoplasmas entering
mouse macrophages in vitro are rapidly killed in phagolysosomes, whereas the
other half of the organisms survive and multiply in phagocytic vacuoles that do
not acquire lysosomal factors (14) . In contrast, more than 90% of thetoxoplasmas
exposed to antibody were rapidly killed, and studies with thorotrast or acid
phosphatase showed that these organisms resided in phagolysosomes . Antibody
exposure thus apparently blocked the ability of some of the parasites to alter the
phagocytic vacuole in such a way as to prevent fusion with lysosomes .
Pretreatment of the host cells, but not of the toxoplasmas with antibody,
followed by washing and infection did not lead to detectable alterations ; the
survival and growth of the organisms was the same as in a system not exposed to
antibody . Furthermore addition of antitoxoplasma antibody to the culture
immediately after infection exerted no effect on the generation time in
macrophages, indicating that intracellular surviving organisms were not availa-
ble to the added antibody .
Multiplication of Toxoplasmas within Macrophages from Normal and Immu-
nized Mice . We proceeded, then, to observations on possible cellular immunity
to toxoplasmas demonstrable in vitro, i.e ., altered growth of the organisms in
cells from immunized animals in the absence of added antibody . The generation470
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time of toxoplasmas in macrophages taken from mice longer than 2 wk after
immunization was markedly prolonged (Table I) . In these experiments both
peritoneal lymphocytes and macrophages were maintained in culture for 24 h in
the presence of toxoplasma antigen before the monolayers were washed ; these
immune adherent cells were then infected with toxoplasmas . At 18 h there was
minimal division oftoxoplasmas in macrophages from immunized mice (mean of
1 .3 t 0.3 toxoplasmas/vacuole), compared to a mean of 5 .2 zE 0.5 parasites/
vacuole in macrophages from normal mice . Calculated generation times were 28
h in cells from immunized mice compared to 5 h in controls .
TABLE I
Generation Times of Toxoplasmas in Peritoneal Macrophages from Normal Animals and
Animals Immunized with Avirulent Toxoplasmas
Macrophages were cultured in vitro for 24 h with peritoneal lymphocytesand 20 Ag/ml of toxoplasma
antigen before infection .
*Calculated by the slope on semilogarithmic graph .
t Indicates the mean and one standard deviation of 20 experiments .
Under phase-contrast microscopy, at 3 h after infection the same percentage of
degenerating toxoplasmas (approximately 50%) was seen in these cells from
immune mice as has previously been described in cells from normal mice (9) . At
time points beyond 3 h, only healthy appearing oval, relatively phase-lucent
parasites could be identified, suggesting that the low number of toxoplasmas per
vacuole in macrophages from immune mice did not reflect persistence of
damaged organisms, or killing and digestion of the organisms over a more
prolonged period than in controls . Furthermore, the percent of macrophages
infected with toxoplasmas was the same in cells from normal and immune
animals during the observation period, indicating no striking difference in initial
uptake into immune or normal cells . Toxoplasmas in vacuoles of macrophages
from immune mice appeared the same as toxoplasmas within macrophages of
normal mice by every parameter, except that they did not divide . The similarity
in morphology of the nondividing parasites in immune macrophages and the
dividing organisms in normal macrophages was confirmed by electron micros-
copy of cultures 24 h after infection . Fig . 1 demonstrates the electron microscopic
appearance of dividing toxoplasmas in normal cells . The ultrastructure of the
parasites is well preserved . The macrophage vacuole is surrounded by mitochon-
dria and endoplasmic reticulum, and contains microvillous structures as
described previously (14) . Fig. 2shows a single toxoplasma in a macrophage from
an immune animal 24 h after infection of the macrophage in vitro . The parasite
appears morphologically normal, and the macrophage vacuoles and surrounding
structures are similar to those seen in the normal macrophage .
Source of
macrophages
No . of
3h
toxoplasmas
10h
pervacuole after
18 h
infection
28 h
Calculated
generation
time*
Toxoplasma 1.0 1.1 1 .3 0.3$ 2.1 28.0
immune mice
Normal mice 1.0 1.6 5.2 t 0.5$ - 5.0FIG. 1.
￿
An electron photomicrographof a macrophage fixed 24 h after toxoplasma infection .
The rosette offour parasites in the center vacuole indicates two divisions . The vacuole is filled
with microvilli arising from the vacuolar membrane .Thevacuole is surrounded in most regions
by endoplasmic reticulum or mitochondria . (x 15,000) .
FIG . 2 .
￿
An electron photomicrograph of a macrophage from atoxoplasma immune animal 24
h after infection in vitro with toxoplasmas . Thetoxoplasma showsnormal morphology but has
not multiplied . The vacuole, surrounding mitochondria and endoplasmic reticulum, and
microvilli are indistinguishable from those seen in the normal infected macrophage . (x
19,500) .
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Requirements for Lymphocytes and for Toxoplasma Antigen for Induction in
Macrophages of the Ability to Suppress Toxoplasma Multiplication, and the
Variation in these Requirements with Time afterImmunization . The ability of
macrophages to inhibit toxoplasma multiplication was found to vary depending
on the cell population or products present, and on the number of days after
immunization that the peritoneal cells were collected . In each experiment the
peritoneal cells were allowed to incubate in vitro for 24 h before challenge with
toxoplasmas, with or without nonadherent lymphoid cells, and with or without
added toxoplasma antigen. All monolayers were then washed free ofnonadherent
cells and antigen before infection of the macrophages with virulent toxoplasmas.
Table II shows the results as toxoplasmas per vacuole at 18 h after in vitro
challenge . When no toxoplasma antigen was added during the prechallenge
incubation, by 16 days a significant inhibition of toxoplasma multiplication was
seen, and this inhibition became maximal at approximately a month after
immunization . By 63 days after immunization, however, this effect was largely
gone . In one experiment almost 1 yr after immunization no inhibition of
toxoplasma multiplication was seen . Inhibition oftoxoplasma multiplication was
observed in the absence of added toxoplasma antigen even when all nonadherent
cells were removed before the prechallenge incubation (second column) in one
experiment 19 days after immunization, but no significant inhibition under these
conditions was observed longer than 49 days after immunization .
More impressive toxoplasma inhibition was observed when the peritoneal cells
TABLE 11
Multiplication of Toxoplasmas in Macrophages Challenged after 24 h of Cultivation with
Lymphocytes andlor Toxoplasma Antigen Related to Time after Immunization with
Avirulent Toxoplasmas
Prechallenge incubation conditions
No . ofdays after
￿
No antigen added
￿
Toxoplasma antigen added
immunization
*Mean number of T . gondii per vacuole 18 h after in vitro challenge .
Mixed
peritoneal cells
Adherent
cells only
Mixed
peritoneal cells
Adherent
cells only
5 5.0* - 5.1 -
9 3.4 - 2.8 -
12 3.3 - 2.2 -
16 2.2 - 1 .3 -
19 - 2.0 1 .3 1 .1
26 2.4 - 1.2 -
33 1 .4 - 1 .4 -
35 1.9 - 1 .1 1 .3
49 - 4.1 1.7 1 .5
63 3.4 4.1 1 .3 1 .2
75 4.8 4.9 1 .6 4.2
77 3.9 - 1.0 -
84 4.5 4.3 1.7 4.1
323 5.7 - 1.9 5.1THOMAS C. JONES, LUCILLE LEN, AND JAMES G. HIRSCH
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were exposed during the prechallenge incubation to toxoplasma antigen . By 16
days after immunization maximum inhibition of toxoplasma growth was evident
(1 .3 toxoplasmas/vacuole), and this inhibition could be demonstrated for nearly
a year after immunization . Removal of nonadherent lymphoid cells before the
prechallenge incubation did not alter the development in the macrophages of the
capacity to inhibit toxoplasma multiplication in cells collected up to 2 mo after
immunization, but thereafter toxoplasma inhibition required the presence of
lymphoid cells as well as toxoplasma antigen during the prechallenge incubation .
It is not clear whether toxoplasma antigen had a direct effect on enhancing
inhibition of toxoplasma multiplication in the macrophages during the period
less than 2 mo after immunization, or whether a small number of contaminating
lymphocytes that might be present even after extensive washing was playing a
role in the phenomenon .
Spleen lymphocytes from immunized mice when cultured 3 days in RPMI and
20% fresh human serum containing 50Ag/ml oftoxoplasma antigen, then exposed
to [ 3H]thymidine for 6 h showed a significantly enhanced proliferative response .
Lymphocytes from immune mice incorporated 6.1 :~z 2.0 x 10 3 cpm of
[3H ]thymidine ; whereas lymphocytes from immune mice not exposed to toxo-
plasma antigen incorporated 1 .6 =E 0 .5 x 10 3 cpm, and lymphocytes from normal
mice cultured in antigen incorporated 2 .0 f 1 .0 x 10 3 cpm .
Further Characterization of the Lymphocyte-Antigen Effect on
Macrophages . To evaluate further the effects of lymphocytes and toxoplasma
antigen under various conditions, washed macrophages from normal or immune
animals were overlaid with various lymphoid cells and antigens . After 24 h
incubation, the lymphoid cells and antigen were removed and the immune status
of the washed macrophages was assessed . Table III shows a summary of these
experiments . Inhibition of toxoplasma multiplication was seen when either
spleen or peritoneal lymphocytes and toxoplasma antigen were placed over
macrophages from toxoplasma immune mice for 24 h before challenge . No
significant inhibition was observed when lymphocytes from immune animals
were placed over normal macrophages, even when three times the lymphocyte
number found to be effective with macrophages from immune animals was
employed . No inhibitory effect oflymphocytes from immune mice on toxoplasma
multiplication in fibroblasts could be demonstrated . The absence ofeffects of the
lymphoid cells from immune mice and antigen on toxoplasmas in normal
macrophages and fibroblasts make it unlikely that the inhibitory phenomenon
was due to interferon-like activity (15) .
Further studies were done on the time relationships of in vitro prechallenge
cultivation of lymphocytes, toxoplasma antigen, and macrophages required for
acquisition of the capacity of the macrophages to suppress multiplication of
toxoplasmas in vitro . These studies were done by adding toxoplasma antigen to
mixtures of peritoneal cells in vitro at varying times before washing the cover
slips and infecting with toxoplasmas . Table IV shows the results . When antigen
was added 6 and 12 h before infection some inhibition oftoxoplasma multiplica-
tion was seen, but 18-24 h of exposure to antigen led to development of maximal
inhibitory activity . Macrophages cultured with lymphoid cells and toxoplasma
antigen longer than 24 h in vitro lost their ability to inhibit toxoplasma474
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TABLE III
Multiplication of Toxoplasmas in Cells from Various Sources Cultivated for 24 h In Vitro
with Different Lymphocyte Populations and 20 pg/ml of Toxoplasma Antigen
Toxoplasma per
* 1.5 x 10 8 nonadherent cells/dish rather than 5 x 105 .
multiplication . When lymphocytes and antigen were added after toxoplasma
infection, no inhibition of multiplication was observed .
Effects on Toxoplasma Multiplication in Macrophages of Supernates of
Immune Lymphocyte-Toxoplasma Antigen Interactions .
￿
When lymphocytes
from immunized animals (2-3 mo after immunization) were cultured with 20
,g/ml of toxoplasma antigen for 24 h, the medium overlying these cells was found
to be highly effective in inducing the inhibition of toxoplasma multiplication in
macrophages from animals immunized more than 3 mo previously . As is seen in
Table V, the characteristics of the inhibitory activity were the same as those seen
with the lymphocytes, i.e . marked inhibition of toxoplasma growth was induced
in macrophages from immunized, but not in macrophages from normal animals .
Active supernates could be generated by toxoplasma antigen and spleen cells as
well as peritoneal lymphoid cells . Significant toxoplasma inhibition could not be
induced in macrophages from normal mice or in fibroblasts with spleen cell
numbers 20 times larger than those effective with macrophages from immunized
animals .
The lack of effects of supernates on normal cells, and also the loss of an effect
when immune macrophages were cultured in vitro for more than 24 h suggested
the possibility that the effect was a complex one requiring the conjoint action of
at least two factors, one released from immune lymphoid cells on exposure to
Cells in prechallenge 24-h incubation
Adherent cells Nonadherent cells
vacuole 18 h after
infection of washed
macrophages or
fibroblasts
Macrophagesfrom toxoplasma im- Peritoneal from toxoplasma immune 1 .7
mune mice mice
Macrophagesfrom toxoplasma im- Spleen from toxoplasma immune 1 .3
mune mice mice
Macrophagesfrom normal mice Peritoneal from normal mice 4.3
Macrophagesfrom normal mice Peritoneal from toxoplasma immune 4.9
mice
Macrophagesfrom normal mice (3x) peritoneal from toxoplasma im- 4.0
mune mice*
Macrophagesfrom normal mice Spleen from toxoplasma immune 3.7
mice
Fibroblasts (L-cells) Peritoneal from toxoplasma 4.7
miceTHOMAS C. JONES, LUCILLE LEN, AND JAMES G. HIRSCH
TABLE IV
Multiplication of Toxoplasmas in Macrophages Depending on Time and
Duration of Exposure of Macrophages to Immune Lymphocytes and
Toxoplasma Antigen
Discussion
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antigen, the other present on macrophages from immunebut notnormal animals
and lost on prolonged culture (perhaps cytophilic antibody) . Therefore, normal
macrophages, or long-term (72 h) cultured macrophages from immunized
animals were first incubated with heat-inactivated immune serum and then
exposed to active supernates ; no induction of the capacity to inhibit toxoplasma
growth was seen in these instances.
Animals may be immunized against T. gondii by inoculation of avirulent strains
of the organism, or by treating animals infected with virulent strains with
antiprotozoal drugs during the early stages of the infection. In either case a
chronic asymptomatic systemic infection develops, which renders the animal
immune to subsequent challenge with virulent toxoplasmas . This immunity
cannot be induced using killed vaccines . It can be passively transferred to
nonimmune animals by spleen or lymph node cells but not by serum (13) . The
protection induced by such transfer is immunologically specific (13), which is
consistent with our present understanding of thymus-dependent lymphocytes
and their role in cellular immune mechanisms (2, 16) . Macrophages from
immunized animals have been described as "activated," andthey have displayed
enhanced ability to control in vitro infection of toxoplasmas as well as of
immunologically unrelated organisms (17, 18) . A clinical correlate of these
observations is the fact that toxoplasmosis in humans is a particularly severe
disease in those with depressed cellular immune mechanisms in spite of high
antitoxoplasma antibody titers . The infection and the immune response to
toxoplasmas does not involve significant granuloma formation, in contrast to
many other intracellular agents . The characteristic evolution of toxoplasma
infection leads to encystment, after which the organisms remain viable in tissues
for long periods of time, without inciting any significant inflammatory response .
A typical delayed hypersensitivity reaction, however, does occur in chronically
Duration of in vitro prechallenge
mixture ofimmune lymphocytes,
macrophages andtoxoplasma antigen
Toxoplasmasper vacuole in macrophages
18 hafterwashingandchallenge
Control (no antigen) 4.0
2h 3 .9
6h 2.9
12h 1 .7
18h 1 .0
21h 1 .0
24 h 1 .2
48 h 2.5
72 h 4.8476
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TABLE V
Multiplication of Toxoplasmas in Cells from Various Sources Treated for 24 h with
Supernates of Either Peritoneal or Spleen Immune Lymphocytes and
Toxoplasma Antigen
Supernate of 24-h incubation
oftoxoplasma antigen and
lymphoid cells from
￿
Toxoplasma per
serum
infected animals in response to subcutaneous injection of toxoplasma antigens .
The observation that toxoplasmas enter phagolysosomes and are destroyed
when they have been pretreated with antitoxoplasma antibody is consistent with
similar results found for other obligate intracellular organisms such as vaccinia
virus (19) and rickettsia (20) . Of interest, Mauel has reported that leishmania do
not appear to respond to antibody in this manner (21) . We have no information
about the mechanism by which the antibody alters the toxoplasmas, rendering
them incapable of "turning off" the lysosomal system locally . The lack of effect of
antibody added after infection in altering viable toxoplasmas in phagocytic
vacuoles is probably due to the inability of the antibody to reach this site, since
these phagocytic vacuoles are rendered incapable of fusing with other pinocytic
and phagocytic vacuoles, as well as lysosomes.
Antibody might well contribute to host resistance to toxoplasmosis by acting
on extracellular organisms released at the time of rupture of infected cells . The
action on extracellular toxoplasmas might be a direct lethal one in conjunction
with available C, or might be an indirect one in which the organisms are rendered
incapable of surviving in macrophages, or incapable of entering nonphagocytic
cells . These effects probably come into play in some circumstances, but the
Adherent cell immune
Lymphoid cell
source
mice
Cell no .
vacuole 18 h
after in vitro
challenge
Macrophages from toxoplasma immune mice Peritoneal 5 x 10' 1 .4
Macrophages from toxoplasma immune mice Spleen 5 x 10' 1 .3
Macrophages from normal mice Peritoneal 1 x 10' 5.1
Macrophages from normal mice Spleen 5 x 10' 4.9
Macrophages from normal mice Spleen 1 x 10' 4.4
Fibroblasts (L cells) Spleen 2 x 10' 3.4
Macrophages from normal mice after culture in Peritoneal 5 x 10' 4.1
10% heat-inactivated immune serum
Macrophages from immune mice 72 h in vitro and Peritoneal 5 x 10' 3.8
after culture in 10% heat-inactivated immuneTHOMAS C. JONES, LUCILLE LEN, AND JAMES G. HIRSCH
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available evidence indicates that the major mechanism involved in protection
against toxoplasmosis is cellular immunity (13, 22) .
A quantitative increase in macrophage-mediated antimicrobial response in
vitro associated with acquisition of cellular immunity by the host has been
demonstrated previously in other systems . For example, an increased listericidal
action in vitro of "activated" macrophages has been shown in a number of
laboratories (8, 17) . The assay for killing of listeria appears to be very sensitive
(even showing increased activity associated with immunization with unrelated
protein antigens [8]), but there remain some uncertainties in interpretation
related to variables such as extracellular multiplication, effects of antibiotics,
microbe viability, and phagocyte cytotoxicity . Also, indirect methods such as
staining or colony counting are necessary, making quantitation somewhat
unreliable . Recently, Mauel has described the use of leishmania species for
evaluating cellular immune responses (21) . These organisms do not survive for
more than 72 h in vitro in normal cells, so that the manifestation of cellular
immunity in vitro required studies on enha ced rate of destruction, not arrest or
reversal of growth of the organisms intracellularly . Similar difficulties have
limited the use of ectromelia virus as a probe of cellular immunity in in vitro
models (23) . Inhibition of mycobacterial multiplication (7) as well as certain
fungi (24) by immune macrophages has been shown, but with these organisms
there may be problems in quantitation similar to those noted with listeria .
The experiments described here in the mouse, and those recently described by
others using mice (17, 22), hamsters (25), and humans (26, 27) have confirmed
the value of the protozoan, T. gondii, for such in vitro quantitative studies. The
technique for determining generation times of toxoplasmas in vitro has been
known for some time . It has been used to document the relationship between
generation time and animal virulence amongvarious strains oftoxoplasmas (28) .
In vitro studies have also been used to document metabolic requirements of
toxoplasmas and their inhibition by various substances (29) . Multiplication of
this organism can be influenced by many factors . For instance, in HeLa cells the
generation time of toxoplasmas is 27 h when cells are maintained in 2% human
serum for 3 days before infection, but only 7 h when 20% serum is used . Raising
the incubation temperature from 37°C to 40°C shortens the generation time in
mouse macrophages from 5 h to approximately 4 h. Various conditions
unfavorable for host cell metabolism in vitro prolong the generation time of
toxoplasmas (unpublished observations) . This body of past experience led us to
utilize rate of toxoplasma multiplication (generation time) in macrophages as a
method in searching for subtle changes associated with the immune state. Mean
generation times in normal macrophages were found to be so consistent that a
single time point 18 h after infection could be used to compare cultures under
different conditions . Lycke andLund in theirearlyexperiments of toxoplasmas in
cell culture found similar reproducibility (30) . In addition to these reproducible
generation times, toxoplasmas offer many other advantages in relation to
quantitative studies of intracellular growth rate . The organisms do not survive or
grow extracellularly, so that no antibiotic need be used . Continuing phagocytosis
of extracellular organisms is not a factor provided that the end point selected for478
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counting is earlier than the time of cell rupture due to intracellular growth .
Furthermore, the assessment ofnumbers of toxoplasmas per cell is made readily
and reliably by direct microscopic examination,
There have been relatively few studies directed at the kinetics of the cellular
immune response in vitro against intracellular microbes . Those working with
Listeria monocytogenes infections have been aware of the "transient" nature of
the cellular immune state, demonstrable 4 days after inoculation of living
listeria, but gone by a few weeks after infection (2) . In mycobacterial infections,
immunity is usually life long though the degree of cutaneous delayed hypersensi-
tivity may be variable (31) . In the case of toxoplasmosis, immunity, skin test
reactivity, and serum antibodies persist for life . These differences are related in
part to the duration that microbes remain viable in the host (1) . Most studies of
macrophage function in vitro have been done a few weeks after immunization
with living microbes or other booster antigenic challenge . These studies have
documented antimicrobial macrophage activity during this period . In the
experiments described in this paper we noted some inhibition of toxoplasma
multiplication without in vitro exposure to lymphocytes or antigen in macro-
phages collected from 2 wk to 2 mo after infection. After this period macrophages
required exposure to immune lymphocytes and toxoplasma antigen in order to
develop full toxoplasma inhibitory activity . Probably the capacity of macro-
phages collected early after the immunizing infection reflects exposure of the
phagocytes to immune lymphoid cells and to toxoplasma antigens in vivo . This
period correlates with the duration of splenomegaly and increased number of
spleen macrophages in infected mice . For the study of induction of immunity in
macrophages by products of the interaction between immune lymphocyte and
toxoplasma antigen, it was thus necessary to use macrophages collected 3 mo or
longer after immunization, a time at which the cells demonstrated little or no
inhibitory activity without exposure to these products .
Preliminary studies have shown that macrophages collected from toxoplasma
immunized mice and maintained in culture for 24 h are more active in converting
[1-''C]glucose to CO, in the resting state than are normal macrophages . This is
true in the case of cells collected longer than 3 mo after immunization .
Apparently, even long after immunization against toxoplasmas, the macrophages
remain "perturbable" and readily responsive to induction of an immune state .
During these studies it was noted that peritoneal macrophages from normal
(unimmunized) mice did not acquire the ability to inhibit toxoplasma multi-
plication in vitro after 24 h of cultivation with toxoplasma immune lymphoid
cells and toxoplasma antigen . Others, employing in vitro models designed to
study cellular immune responses (8, 18, 27, 32) have shown that the inhibitory or
microbicidal activity could be conferred on "normal" macrophages by products
of lymphoid cells from immune animals . Possible explanations for the failure of
induction of immunity in normal macrophages in the toxoplasma system include
the following : (a) Perhaps macrophages must be stimulated in some way before
they can respond to the toxoplasma lymphokines . The observation that macro-
phages from mice immunized against toxoplasmas are metabolically more active
in the resting state than unstimulated mouse peritoneal macrophages is
consistent with this view ; and (b) perhaps immunologically specific cytophilic
antibody (33) or other cytophilic factors (34) on the macrophages arenecessary inTHOMAS C. JONES, LUCILLE LEN, AND JAMESG. HIRSCH
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addition to immune lymphocyte products for complete expression of the
inhibitory activity . Our studies showing that even macrophages from immunized
animals lose responsiveness to lymphokines in vitro during 2-3 days of cultiva-
tion is consistent with such a hypothesis, since membrane turnover might well
result in the loss of such cytophilic substances .
The experiments described here have shown that a lymphocyte product
generated by cultivation of immune lymphocytes and toxoplasma antigen for 24
h in vitro can induce the inhibitory effect on toxoplasmas within certain
macrophages . Characterization of this lymphocyte product is now underway ;
preliminary results indicate that it is stable to freezing at -70°C for several
months, and stable to 56°C for 30 min; it is inactivated by heated mouse plasma
and by trypsin. The product is released under circumstances which cause a
lymphocyte proliferative response as measured by [3H]thymidine incorporation.
The nature of the macrophage alteration responsible for the inhibition of
toxoplasma growth remains to be defined . Electron microscopy oftoxoplasmas in
these "immune" macrophages has demonstrated the parasites to be intact,
without evidence of morphological degenerative changes 24 h after infection, and
without evidence of lysosomal fusion with the vacuole containing the parasite,
using a thorotrast lysosomal label as previously described (14) . Others have
reported degeneration of toxoplasmas (as documented by alteration of staining
characteristics) within macrophages of the immune animal (26) . We have not
extended our studies to determine the ultimate fate of these slowly dividing or
nondividing organisms . They might degenerate eventually, or they might evolve
into a toxoplasma cyst, a hallmark of the immune state in toxoplasma infection .
In any event the initial cellular immune response appears to be an inhibition of
toxoplasma multiplication, rather than a toxoplasmacidal one. Similar initial
changes have also been suggested by studies in vitro of mycobacteria (32, 35) and
histoplasma (24) in immune cells .
The lack of specificity in the effector arm of cellular immunity, i.e . the
increased macrophage microbicidal activity, was first described by Mackaness
(36), and by Elberg et al . (37) over a decade ago . Our observations on specificity
in cellular immunity to toxoplasmosis are not yet complete, but we have observed
that macrophages from BCG-immunized animals placed in culture with purified
protein derivative of tuberculin and TB-immune lymphocytes do not inhibit
toxoplasma growth, nor do macrophages harvested after intravenous Listeria
infection, nor macrophages taken from peritoneal cavities stimulated by mineral
oil or endotoxin . These findings are consistent with other observations recently
reported indicating that control oftoxoplasma infection by nonspecific activation
may be somewhat more difficult than control of listeria infection (15, 25) . In any
event, further studies are required in order to establish the physiological
alterations induced in macrophages in acquired cellular immunity, andto answer
questions about possible differences in these alterations in the various experi-
mental systems.
Summarv
Studies have been made on humoral and cellular immune responses in mice
immunized with an attenuated strain of Toxoplasma gondii . Heat-inactivated480
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antitoxoplasma serum did not cause morphologic changes in the organisms, but
did markedly influence their interactions with host cells . Toxoplasmas exposed
to antibody were no longer capable of entering fibroblasts or HeLa cells. They
were readily engulfed by macrophages, but the antibody treatment strikingly
altered the intracellular fate of the parasites leading to killing and digestion of
the toxoplasmas in phagolysosomes . Addition of antitoxoplasma antibody
immediately after infection of macrophages in vitro had no effect on intracellular
multiplication of the organism .
The division time of virulent toxoplasmas in mouse peritoneal macrophages in
vitro was markedly prolonged in cells from immunized mice . During the first 2-3
mo after immunization, the macrophages harvested from the peritoneal cavity
demonstrated this cellular immunity directly ; thereafter exposure of the macro-
phages to immune lymphocytes and toxoplasma antigen, or to supernates from
such an interaction was required for induction of the maximal capacity to inhibit
growth of toxoplasmas. Induction of the alteration in macrophages by the
lymphocyte product was detectable in 6 h and maximal at 18-24 h.
Cultivation in vitro of macrophages from immunized animals for periods
longer than 48 h rendered the cells nonresponsive totheimmune lymphocyte-tox-
oplasma product . Macrophages from the peritoneal cavities of normal, nonim-
munized mice were also incapable of developing the capacity to inhibit growth of
toxoplasmas in response to this product . The nonresponsiveness of normal
macrophages, or of macrophages cultured for several days in vitro was not
changed by exposure of the cells to antitoxoplasma serum.
Received for publication 31 October 1974 .
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